Dynamic Studies Demo

Study	PI	Collection	Subjects with DNA	Links to Data*
Study 01 - Genetics of Opioid Dependence	Joel Gelernter	Opioid-Cocaine Dependence	4,848	NIDA Repository
Study 02 - Mapping Susceptibility Genes for Nicotine Dependence	Ming D. Li	Nicotine Dependence	1,962	NIDA Repository
Study 03 - Molecular Genetics of Heroin Dependence in China	Ming Tsuang	Opioid Dependence	1,232	NIDA Repository, dbGaP
Study 05 - Addictions, Genotypes, Polymorphisms, and Function	Mary Jeanne Kreek	Opioid Dependence	1,751	NIDA Repository, dbGaP
Study 06 - The Genetics of Vulnerability to Nicotine	Pamela Madden	Nicotine Dependence	2,663	NIDA Repository, dbGaP
Study 07 - An Introduction to the Family Study of Cocaine	Laura Bierut	Cocaine Dependence	1,049	NIDA Repository
Study 08 - Mu Opioid Receptor Gene in Heroin Addicts	Lei Yu	Opioid Dependence		Combined with Study 5
Study 09 - Differentiation of Phenotypes for Smoking: Administrative Supplement to Join NIDA Genetics Consortium	Ovide Pomerleau	Nicotine Dependence	1,540	NIDA Repository
Study 10 - Pharmacokinetics of Nicotine in Twins	Gary Swan	Nicotine Dependence	62	NIDA Repository
Study 11 - Adolescent Drug Dependence	John Hewitt	Polysubstance Dependence	1,589	NIDA Repository
Study 12 - Substance Abuse and the Dopamine System Genes	Michael M. Yanyukov	Polysubstance Dependence	470	NIDA Repository
Study 13 - Genetics of Cocaine Induced Psychosis	Joseph F. Cubells	Cocaine Dependence	230	NIDA Repository
Study 14 - Genome-Wide Analysis for Addiction Susceptibility Genes	Herb Lachman	Opioid Dependence	693	NIDA Repository, dbGaP
Study 15 - Nicotine Dependence	Laura Bierut	Nicotine Dependence	3,424	NIDA Repository
Study 16 - Nicotine Dependence	Mark Leppert	Nicotine Dependence	917	NIDA Repository
Study 17 - Opioid Dependence	Wade Berrettini	Opioid Dependence	200	NIDA Repository
Study 18 - Opioid Dependence: Candidate Genes and G x E Effects	Elliot Nelson	Opioid Dependence	1,895	NIDA Repository
Study 19 - Epidemiological Study of Substance Abuse	Rob Philibert	Polysubstance Dependence	520	NIDA Repository
Study 20 - Innovative Approaches for Cocaine Pharmacotherapy	Henry Kranzler	Opioid-Cocaine Dependence	219	NIDA Repository
Study 21 - Twin Family Study of Vulnerability to Substance Abuse	William Iacono	Polysubstance Dependence		Combined with Study 25
Study 22 - Exploring the Genetic Basis for Drug Use	Hallam Hurt	Polysubstance Dependence		Closed
Study 23 - Substance Use Disorder Liability: Candidate Gene System	Michael M. Vanyukov	Polysubstance Dependence	886	NIDA Repository
Study 24 - START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies (START)	Wade Berrettini	Opioid Dependence	785	NIDA Repository, dbGaP
Study 25 - The Genes, Environment, and Development Initiative (GEDI)	William Iacono	Other		dbGaP
Study 26 - The Genes, Environment, and Development Initiative (GEDI)	E. Jane Costello	Other		dbGaP
Study 27 - The Genetic Study of Nicotine Dependence in African Americans (AAND)	Laura Bierut	Nicotine Dependence	1,792	NIDA Repository
Study 28 - Center on Antisocial Drug Dependence: the Genetics of HIV Risk Behavior	John Hewitt	Other		NIDA Repository*
Study 29 - Genetics Protocol of the Cocaine Use Reduction with Buprenorphine (CURB) Study; CTN-0048	David A. Nielsen	Cocaine Dependence	278	Clinical Trials Network
Study 30 - Phase 2: Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Trial of Nepicastat for Cocaine Dependence	Thomas R. Kosten	Cocaine Dependence		NIDA Repository*
Study 31 - Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT); CTN-0051	John Rotrosen	Smokescreen	615	dbGaP, Clinical Trials Network
Study 32 - Achieving Cannabis Cessation-Evaluation of N-Acetylcysteine (ACCENT); CTN-0053	Kevin Gray	Other	204	Clinical Trials Network
Study 33 - Genome-wide Association Study of HIV-1 Host Genetics Among Injection Drug Users	Eric Johnson	Other		dbGaP
Study 34 - Attention Deficit-Hyperactivity Disorder (ADHD)	Robert K. Moyzis	Other		NIDA Repository*
Study 35 - Genetically Informative Smoking Cessation Trial	Li-Shiun Chen	Nicotine Dependence	873	NIDA Repository
Study 36 - Genetic Dissection in Pedigrees of Substance Use and Mood Disorders Comorbidity	Nelson B. Freimer	Other		NIDA Repository*
Study 37 - Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder; CTN-0068	Madhukar Trivedi	Other	243	Clinical Trials Network
Study 38 - Adolescent Brain Cognitive Development (ABCD) Study		Other	10,217	NIMH Data Archive
Study 39 - Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone: Improving the Real-World Effectiveness of Injection Naltrexone for Opioid Use Disorder (SWIFT); CTN-0097	Adam Bisaga	Opioid Dependence	246	Clinical Trials Network*
Study 40 - Exemplar Hospital Initiation Trial to Enhance Treatment Engagement (EXHIT ENTREY); CTN-0098	Gavin Bart	Opioid Dependence	15	Clinical Trials Network*
Study 41 - Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy; CTN-0100	Edward Nunes	Opioid Dependence	472	Clinical Trials Network*
Study 42 - Genetics Analysis of Substance Use Disorder Using the Indiana Biobank Data	Dongbing Lai	Other		dbGaP*
Study 43 - Pediatric Imaging, Neurocognition, and Genetics (PING)	Terry Jernigan	Other		TBA
Study 44 - Randomized, Placebo-Controlled Trial of Injectable Naltrexone and Monthly Injectable Buprenorphine for Cocaine Use Disorder (CURB-2); CTN-0109	Madhukar Trivedi	Cocaine Dependence		Clinical Trials Network*
Study 45 - Randomized, Double-Blind, Placebo-Controlled Trial of Monthly Injectable Buprenorphine for Methamphetamine Use Disorder (MURB); CTN-0110	Steve Shoptaw	Polysubstance Dependence		Clinical Trials Network*
Study 46 - Advancing Genomics Research of Substance Use Disorders in Latin American Populations	Janitza Montalvo-Ortiz & Humberto Nicolini	Polysubstance Dependence		TBA
Study 51 - Genotyping on Smokescreen Microarray Chip	Jasmin Vassileva & Alexandre Todorov	Smokescreen		dbGaP studies: phs001647, phs001804
Study 52 - Genetic Contribution to the Abuse Liability of Oxycodone	Jermaine Jones	Smokescreen		dbGaP
Study 53 - The Women’s Interagency HIV Study (WIHS)	Brad Aouizerat	Smokescreen		dbGaP
Study 54 - Genotyping on Smokescreen Microarray Chip	Deborah Mash	Smokescreen		dbGaP
Study 55 - ALIVE Cohort Smokescreen GWAS	Brion Maher	Smokescreen		dbGaP
Study 56 - Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with IV Methamphetamine	Edythe London	Smokescreen		dbGaP
Study 57 - Neural Systems, Inhibitory Control, and Methamphetamine Dependence	Edythe London	Smokescreen		dbGaP
Study 58 - Early Methamphetamine Abstinence fMRI and Brain Function	Edythe London	Smokescreen		dbGaP
Study 59 - Smokescreen; Opioid/Cocaine Use; Antisocial Drug Dependence	Robin Corley	Smokescreen		dbGaP
Study 60 - Gene-Environment Interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Cocaine Addiction	Rodrigo Grassi-Oliveira	Smokescreen		dbGaP
Study 61 - Smokescreen; NJD/NID Cohort	Stanley Weiss	Smokescreen		dbGaP
Study 62 - Prevention of Viral Hepatitis and HIV in Drug Users - A Hepatitis B Model for HIV and an HB Vaccine Model (DASH)	Lu-Yu Hwang	Smokescreen		dbGaP
Study 63 - Smokescreen; InC3 Cohort Substance Abusers	Kimberly Page	Smokescreen		dbGaP
Study 64 - Smokescreen; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)	Inga Peter	Smokescreen		dbGaP
Study 65 - Spit for Science	Danielle Dick	Smokescreen		dbGaP

Generated by wpDataTables